Dorronzoro-Ramirez Emilio, Sanchez-Tena Miguel Angel, Alvarez-Peregrina Cristina, Cardenas Rebollo Jose Miguel, Flores Cervantes Dayan, Sánchez-Ramos Celia
Faculty of Medicine, CEU-San-Pablo University, 28925 Madrid, Spain.
Hospital Universitario Sanitas La Moraleja, 28050 Madrid, Spain.
J Clin Med. 2025 Aug 23;14(17):5953. doi: 10.3390/jcm14175953.
: Age-related macular degeneration (AMD) is a leading cause of visual impairment in older adults and often coexists with cataracts. The indication of presbyopia-correcting intraocular lenses (IOLs) in these patients remains controversial. This study aimed to evaluate the clinical performance of a non-diffractive extended depth-of-focus (EDOF) IOL (LuxSmart™) compared to a monofocal plus IOL (Tecnis Eyhance™) in cataract patients with early-stage dry AMD. : In this prospective observational study, 41 patients with early-stage AMD underwent bilateral cataract surgery with either LuxSmart™ or Tecnis Eyhance™ IOL implantation, targeting postoperative emmetropia. The eye selected for analysis was the first eye scheduled for surgery. Preoperative and postoperative evaluations included high and low-contrast distance visual acuity, intermediate and near visual acuity, defocus curves, ocular light scatter (halometry), and quality of life assessment (NEI VFQ-25). Postoperative biometric accuracy and refractive outcomes were also analyzed. : Both IOLs showed high refractive accuracy, with 100% of eyes within ±0.50 D of target. Postoperative uncorrected distance visual acuity was 0.10 ± 0.06 LogMAR for Eyhance and 0.07 ± 0.02 for LuxSmart ( = 0.06). Low contrast VA at 20% was 0.22 ± 0.11 (Eyhance) and 0.26 ± 0.16 (LuxSmart) ( = 0.49). Depth of focus was approximately 1.75 D for both lenses. Light scatter (LDI) improved postoperatively in both groups with no significant differences ( = 0.54). VFQ-25 scores showed improvement in daily activities, though no changes were observed in driving or mental health domains. : Both lenses are safe and effective options for early AMD patients undergoing cataract surgery, providing good functional vision at multiple distances.
年龄相关性黄斑变性(AMD)是老年人视力损害的主要原因,且常与白内障并存。在这些患者中,用于矫正老花眼的人工晶状体(IOL)的适应证仍存在争议。本研究旨在评估一种非衍射性扩展焦深(EDOF)人工晶状体(LuxSmart™)与单焦点附加人工晶状体(Tecnis Eyhance™)相比,在早期干性AMD白内障患者中的临床性能。
在这项前瞻性观察研究中,41例早期AMD患者接受了双侧白内障手术,分别植入LuxSmart™或Tecnis Eyhance™人工晶状体,目标是术后正视。选择用于分析的眼睛是第一只安排手术的眼睛。术前和术后评估包括高对比度和低对比度远视力、中视力和近视力、散焦曲线、眼内光散射(散射光度法)以及生活质量评估(NEI VFQ-25)。还分析了术后生物测量准确性和屈光结果。
两种人工晶状体均显示出高屈光准确性,100%的眼睛在目标值±0.50 D范围内。Eyhance术后未矫正远视力为0.10±0.06 LogMAR,LuxSmart为0.07±0.02(P = 0.06)。20%对比度下的低对比度视力,Eyhance为0.22±0.11,LuxSmart为0.26±0.16(P = 0.49)。两种晶状体的焦深约为1.75 D。两组术后光散射(LDI)均有改善,无显著差异(P = 0.54)。VFQ-25评分显示日常活动有所改善,但在驾驶或心理健康领域未观察到变化。
对于接受白内障手术的早期AMD患者,两种晶状体都是安全有效的选择,可在多个距离提供良好的功能性视力。